Publicaciones en las que colabora con RAFAEL GONZÁLEZ CANO (7)

2023

  1. Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity

    Journal of Medicinal Chemistry, Vol. 66, Núm. 16, pp. 11447-11463

2021

  1. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain

    Pharmacological Research, Vol. 163

  2. Tetrodotoxin, a potential drug for neuropathic and cancer pain relief?

    Toxins, Vol. 13, Núm. 7

2020

  1. El receptor sigma-1: una diana farmacológica que modula las interacciones neuroinmunitarias y neurogliales durante el dolor crónico

    Actualidad en farmacología y terapéutica, Vol. 18, Núm. 3, pp. 173-186

  2. The search for translational pain outcomes to refine analgesic development: Where did we come from and where are we going?

    Neuroscience and Biobehavioral Reviews, Vol. 113, pp. 238-261

2018

  1. Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists

    Pharmacological Research, Vol. 131, pp. 224-230

2017

  1. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 31, pp. 8396-8401